Synopsis of Social media discussions

Several discussions reference the trial's early termination due to perceived futility, highlighting a sense of disappointment or skepticism. Phrases like 'not much has changed' and 'similar outcomes' emphasize a critical view on the ablation versus rate control debate. The nuanced tone illustrates a blend of expectation and caution, reflecting the complexity and evolving nature of treatment practices in heart failure patients.

A
Agreement
Neither agree nor disagree

The discussions reveal mixed reactions regarding the trial's findings, with some seeing merit in its conclusions while others express disappointment.

I
Interest
Moderate level of interest

Participants show moderate interest, questioning implications and contextualizing the findings within existing research.

E
Engagement
Moderate level of engagement

There are instances of deeper analysis, as some commenters reference specific outcomes and trends from the trial's data.

I
Impact
Moderate level of impact

Overall, users perceive a moderate impact of the trial on future clinical practices, with varying opinions on its significance.

Social Mentions

YouTube

2 Videos

Facebook

2 Posts

Twitter

92 Posts

Blogs

2 Articles

News

2 Articles

Metrics

Video Views

42

Total Likes

232

Extended Reach

338,095

Social Features

100

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

New Insights on Atrial Fibrillation and Treatment Strategies

New Insights on Atrial Fibrillation and Treatment Strategies

This week, John Mandrola MD discusses three key aspects of the recent AF guidelines, emphasizing early rhythm-control therapy's potential to reduce cardiovascular risks. Join us for an in-depth analysis of the latest recommendations and emerging treatment options for POTS.

March 27, 2024

32 views


Ablation vs Rate Control in Heart Failure with Atrial Fibrillation

Ablation vs Rate Control in Heart Failure with Atrial Fibrillation

This podcast discusses the RAFT-AF trial, which compared ablation-based rhythm control versus rate control in heart failure patients with atrial fibrillation. While the study showed no significant differences in primary outcomes, secondary measures indicated improvements in left ventricular function and quality of life.

March 27, 2024

11 views


  • ぽん@
    @pharma_pon (Twitter)

    心不全および心房細動患者におけるアブレーションに基づくリズムコントロールとレートコントロールのランダム化比較試験:RAFT-AF試験の結果 https://t.co/abATesIeha
    view full post

    August 11, 2025

    6

  • Hiroyuki Sato 佐藤宏行
    @foreverhero0819 (Twitter)

    RT @Crypto1835: RAFT-AF(サブ解析) EF<45%  https://t.co/YkfQ5C4TiC #EP大学
    view full post

    June 7, 2023

    1

  • まめたろう,MD, PhD
    @mameeps (Twitter)

    RAFT-AF(サブ解析) EF<45%  https://t.co/YkfQ5C4TiC #EP大学
    view full post

    June 7, 2023

    7

    1

  • Samuel Barreto
    @Barreticos01 (Twitter)

    RT @jsenior64: Finalmente, otro estudio podría darnos la respuesta, siempre y cuando reforzara los hallazgos del CASTLE HF, sin embargo pas…
    view full post

    June 5, 2023

    1

  • Juan Senior
    @jsenior64 (Twitter)

    Finalmente, otro estudio podría darnos la respuesta, siempre y cuando reforzara los hallazgos del CASTLE HF, sin embargo pasó todo lo contrario. Si miran la curva de mortalidad se darán cuenta que son similares hasta los dos años y luego logran separarse. https://t.co/9V6EYg51yn
    view full post

    June 5, 2023

    1

    1

  • javad mikaeili
    @javadm20 (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    October 14, 2022

    32

  • Trip Database
    @tripdatabase (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/kdjMk2mDhu
    view full post

    August 12, 2022

  • Trip Primary Care
    @TripPrimaryCare (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/YirSZyk0Lb
    view full post

    August 11, 2022

  • Trip Primary Care
    @TripPrimaryCare (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/YirSZyk0Lb
    view full post

    August 9, 2022

  • Trip Database
    @tripdatabase (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/kdjMk2mDhu
    view full post

    August 7, 2022

  • 仲間 達也 / Tatsuya Nakama
    @tatsuya_nakama (Twitter)

    RT @sk2798: Thank you for featuring our paper. We believe that the findings also resonate well with the results from the RAFT-AF trial (htt…
    view full post

    August 3, 2022

    4

  • 香坂 俊
    @sk2798 (Twitter)

    Thank you for featuring our paper. We believe that the findings also resonate well with the results from the RAFT-AF trial (https://t.co/qjoeGXYiWJ). Very much looking forward to further progress in this area of research! https://t.co/p3aQBqKtnU
    view full post

    August 3, 2022

    20

    4

  • Trip Primary Care
    @TripPrimaryCare (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/YirSZyk0Lb
    view full post

    July 31, 2022

  • Trip Database
    @tripdatabase (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/kdjMk2mDhu
    view full post

    July 30, 2022

  • Trip Primary Care
    @TripPrimaryCare (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/YirSZyk0Lb
    view full post

    July 26, 2022

  • Trip Primary Care
    @TripPrimaryCare (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/YirSZyk0Lb
    view full post

    July 20, 2022

  • Trip Database
    @tripdatabase (Twitter)

    New2Trip: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients w/ Heart Failure & Atrial Fibrillation: Results from RAFT-AF trial https://t.co/kdjMk2mDhu
    view full post

    July 17, 2022

  • Hiroyuki Sato 佐藤宏行
    @foreverhero0819 (Twitter)

    ⬇️本文はこちらから https://t.co/KDWVDcVz3s
    view full post

    June 29, 2022

  • 東北大学 循環器内科
    @cardio_tu (Twitter)

    2 min Cardiology(臨床論文、担当:佐藤宏行) Randomized ablation-based rhythm control versus rate-control trial in patients with heart failure and atrial fibrillation : Results from the RAFT-AF trial Circulation 2022, June 7. #Cardiology
    view full post

    June 29, 2022

    2

  • Antonio Manteca
    @amango30 (Twitter)

    RT @RevistaMFSamfyc: Ensayo aleatorizado de ablación según ritmo frente a según frecuencia en pacientes con insuficiencia cardiaca y fibril…
    view full post

    June 21, 2022

    1

  • Revista MFAndalucia
    @RevistaMFSamfyc (Twitter)

    Ensayo aleatorizado de ablación según ritmo frente a según frecuencia en pacientes con insuficiencia cardiaca y fibrilación auricular: resultados del ensayo RAFT-AF https://t.co/VB9ZZCb76u PMID 35313733
    view full post

    June 21, 2022

    1

    1

  • Takeki Suzuki
    @takekisuzuki (Twitter)

    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial https://t.co/hub3GwolX6
    view full post

    June 7, 2022

    1

  • Yuleisy A. De la Rosa Rojas
    @YuleisyADelaRo1 (Twitter)

    RT @CampusArritmias:
    view full post

    April 12, 2022

    4

  • QxMD | Your Personalized Medical Journal
    @QxMD (Twitter)

    Trending on #ReadbyQxMD. The RAFT-AF trial from @CircAHA is being hotly discussed given it's possible impact on future practice and guidelines. Check it out via the link below. https://t.co/eZvEF89KNZ #CardioTwitter #ACC22 https://t.co/Rhvdo0TiS8
    view full post

    April 5, 2022

  • Rodrigo Nunes Cal
    @CalZole (Twitter)

    RT @CircAHA: #OriginalResearch: In the #RAFTAF #RCT, there was
    view full post

    April 2, 2022

    7

  • Steve Wilton
    @SBWilton (Twitter)

    RT @CircAHA: #OriginalResearch: In the #RAFTAF #RCT, there was
    view full post

    April 1, 2022

    7

  • Ron Ree
    @ronmree (Twitter)

    RT @CircAHA: #OriginalResearch: In the #RAFTAF #RCT, there was
    view full post

    April 1, 2022

    7

  • Hiroyuki Sato 佐藤宏行
    @foreverhero0819 (Twitter)

    RT @CircAHA: #OriginalResearch: In the #RAFTAF #RCT, there was
    view full post

    April 1, 2022

    7

  • Joseph hill
    @josephahill (Twitter)

    RT @CircAHA: #OriginalResearch: In the #RAFTAF #RCT, there was
    view full post

    April 1, 2022

    7

  • Dorian L. Beasley MD, FACC
    @cardiojaydoc02 (Twitter)

    RT @CircAHA: #OriginalResearch: In the #RAFTAF #RCT, there was
    view full post

    April 1, 2022

    7

  • Circulation
    @CircAHA (Twitter)

    #OriginalResearch: In the #RAFTAF #RCT, there was
    view full post

    April 1, 2022

    10

    7

  • British Society for Heart Failure #theFword
    @BSHeartFailure (Twitter)

    Some striking features: high procedure-related complications (11%) even though in top centres. Took 6 years to recruit. Circulation 2022 https://t.co/pnq6mNjGYD
    view full post

    April 1, 2022

    2

  • British Society for Heart Failure #theFword
    @BSHeartFailure (Twitter)

    RAFT-AF published on line: no effect of AF ablation in HF on all-cause mortality + all HF events. Circulation 2022 https://t.co/pnq6mNjGYD
    view full post

    April 1, 2022

    4

  • Umar Shakur
    @u_shakur (Twitter)

    Strict rate control compared well to rhythm control in AF+HF; maybe lenient rates (RACE-II) not best Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial https://t.co/tJcY6BvdB7
    view full post

    March 30, 2022

  • Juan Pablo Costabel MD
    @jpcostabel (Twitter)

    https://t.co/qnev86wyet
    view full post

    March 27, 2022

    5

  • Sebastian Feickert
    @sebFeickert (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 27, 2022

    32

  • Andreas Rillig
    @AndreasRillig (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 26, 2022

    32

  • Jorge Toquero
    @JorgeToquero (Twitter)

    RT @CampusArritmias:
    view full post

    March 25, 2022

    4

  • EP_Bot
    @EPeeps_Bot (Twitter)

    RT @CampusArritmias:
    view full post

    March 25, 2022

    4

  • Victor Castro Urda
    @VictorCastroUrd (Twitter)

    RT @CampusArritmias:
    view full post

    March 25, 2022

    4

  • Campus de Arritmias
    @CampusArritmias (Twitter)


    view full post

    March 25, 2022

    6

    4

  • Takeki Suzuki
    @takekisuzuki (Twitter)

    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial https://t.co/biM5QXrqmm
    view full post

    March 24, 2022

    1

  • ASANO
    @ShunASN_circ (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 24, 2022

    32

  • Morio
    @MorioOno1 (Twitter)

    RT @Yuki_Sahashi: NYHA2-3の心房細動(high burden PAF&PerAF)LVEFも6割程度が <35%のTable1 このような中~高リスク患者であれば、アブレーション治療のほうが、composite (mortality % HF admi…
    view full post

    March 24, 2022

    3

  • Dr. Zhong
    @pzhong2016 (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 24, 2022

    32

  • Juan Senior
    @jsenior64 (Twitter)

    Ablación en pacientes con FA y falla cardiaca detenido por futilidad. No impacta desenlace primario, aunque si algunos subrogados. https://t.co/9V6EYg51yn
    view full post

    March 24, 2022

  • たーー
    @FNt1UpCfUH7rFNm (Twitter)

    RT @Yuki_Sahashi: NYHA2-3の心房細動(high burden PAF&PerAF)LVEFも6割程度が <35%のTable1 このような中~高リスク患者であれば、アブレーション治療のほうが、composite (mortality % HF admi…
    view full post

    March 24, 2022

    3


  • @can_yontar (Twitter)

    Results from the RAFT-AF trial: EF, functional capacity, life quality improves but not all cause mortality and HF measures https://t.co/ISWIcJGDDE
    view full post

    March 24, 2022

    1

  • Dr. Michael Alexander
    @MichaelAlexandp (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 24, 2022

    32

  • G. Stuart Mendenhall, MD
    @GSMedicine (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 24, 2022

    32

  • Canadian Heart Rhythm Society
    @CHRS_SCR (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Mihail G. Chelu, MD, PhD
    @MihailChelu (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Eugene Crystal MD FRCPC
    @EugeneCrystal2 (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Jag Singh
    @JagSinghMD (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Department of Medicine (DoM) Research
    @research_dal (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Imane EH
    @EH_Imane (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • JK Han MD
    @netta_doc (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Stuart Harris
    @heartrhythmdoc (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Yuki Sahashi
    @Yuki_Sahashi (Twitter)

    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial from Canada
    view full post

    March 23, 2022

  • Yuki Sahashi
    @Yuki_Sahashi (Twitter)

    NYHA2-3の心房細動(high burden PAF&PerAF)LVEFも6割程度が <35%のTable1 このような中~高リスク患者であれば、アブレーション治療のほうが、composite (mortality % HF admission)では有意かと思っていたので少し驚き https://t.co/zd4JpvQoO8
    view full post

    March 23, 2022

    17

    3

  • Luigi Di Biase
    @LuigiDiBiaseMD (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Ahmet Taha Alper
    @AlperDra (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Steve Greene
    @SJGreene_md (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Dan Ramirez
    @fdanielramirez (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Muthu Vaduganathan
    @mvaduganathan (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Steve Wilton
    @SBWilton (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 23, 2022

    13

  • Bogdan Enache
    @bogdienache (Twitter)

    @Dominik_Linz @FH_Verbrugge @YMareev @FudimMarat @VKutyifa @AndreasGevaert @F_dalgaard @SolovevaAnzhela @DrMikeDrozd @MihaiTrofenciuc And things will only fall further apart between HF and EP… https://t.co/WUflhx0q3O https://t.co/4gWdmr6bBp
    view full post

    March 23, 2022

    3

  • Tom Englezos
    @tomenglezos (Twitter)

    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial https://t.co/0sWpKuGB0X
    view full post

    March 23, 2022

  • Boback Ziaeian
    @boback (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Akiva Rosenzveig
    @AkivaRosenzveig (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Joseph Elias, MD
    @JjeJoseph (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Rakesh Gopinath
    @drrakeshg1 (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Matthew Goldstein
    @mattaustein (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Dalila Masic
    @DMasicPharmD (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • So Sunny
    @SoSunny14 (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Takanori Yamaguchi
    @tayamagu (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Enes Elvin Gul, MD, FESC, FEHRA
    @enes_elvin (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Dahyr Olivas MD
    @ElArritmiologo (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Thomas Deneke
    @EPDeneke (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Nguyễn Khắc Thiên Chương
    @KhacThienChuong (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • Dr. Ozgur Surgit M.D. Prof. Dr.
    @ozgursurgitMD (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 23, 2022

    32

  • CANet
    @CANetInc_ (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 22, 2022

    13

  • Narut
    @prasitlumkum (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 22, 2022

    32

  • Larry Sterns
    @SternsLarry (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 22, 2022

    13

  • Richard Clark
    @RichClarkFHRS (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 22, 2022

    13

  • Kenta Tsutsui
    @KentaTsutsui (Twitter)

    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial | Circulation https://t.co/LyoChYBCdX
    view full post

    March 22, 2022

  • Penn Electrophysiology Fellowship
    @PennEPFellows (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 22, 2022

    32

  • Jacqueline Joza
    @Dr_JozaEP (Twitter)

    RT @ratika_parkash: Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillati…
    view full post

    March 22, 2022

    13

  • Luka Petrovic
    @LBBB_13 (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 22, 2022

    32

  • Tacumi Yamamoto
    @TacumiYamamoto (Twitter)

    RT @Dr_Santangeli: RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction…
    view full post

    March 22, 2022

    32

  • Pasquale Santangeli
    @Dr_Santangeli (Twitter)

    RAFT-AF just published. Trial stopped early by DSMB for apparent futility. However, there was a trend towards reduction in mortality (HR 0.71, 95% CI 0.49-1.03), and statistically significant improvement in LVEF, QoL and 6MWT in the ablation arm https://t.co/JO4ghZqwji
    view full post

    March 22, 2022

    112

    32

  • Ratika Parkash
    @ratika_parkash (Twitter)

    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: results from the RAFT-AF trial https://t.co/6USscnP9Vi @AnthonyTang6 @EPjeff17 @CHRS_SCR @CANetChat
    view full post

    March 22, 2022

    33

    13

Abstract Synopsis

  • The RAFTAF trial compared ablation-based rhythm control with rate control in heart failure patients with atrial fibrillation (AF).
  • The trial included 411 patients and aimed to improve clinical outcomes, with the primary outcome involving all-cause mortality and heart failure events.
  • The study was halted early due to a lack of benefit, showing no significant difference in primary outcomes, although secondary measures indicated improvements in left ventricular function and quality of life for the ablation group.